S-EPMC12352230 - Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansion - OmicsDI

Unknown

Dataset Information

Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansion

ABSTRACT:

SUBMITTER: Kilic I

PROVIDER: S-EPMC12352230 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature